Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• Tumor lymphatics facilitate cancer metastasis by transporting malignant cells to lymph nodes.
• Tumor lymphatic sprouting is primarily attributed to factors from tumor-associated macrophages (TAMs) and cancer cells.
• Emerging evidence highlights a specific TAM subset, myeloid-lymphatic endothelial cell progenitors (M-LECP), in lymphatic expansion.

Purpose of the Study:

• To review the current evidence on the origin, recruitment, and function of M-LECP.
• To explore the mechanisms by which M-LECP promote tumor lymphangiogenesis.
• To discuss the integration of M-LECP into lymphatic vessels and its implications.

Main Methods:

• Review of existing literature on M-LECP.
• Analysis of M-LECP markers and their relation to other cell types.
• Discussion of proposed mechanisms of M-LECP action in tumor environments.

Main Results:

• M-LECP originate from bone marrow monocyte-macrophage precursors.
• M-LECP co-express markers for lymphatic endothelial cells, stem cells, M2 macrophages, and immunosuppressive myeloid cells.
• M-LECP contribute to lymphangiogenesis via paracrine factors and autonomous activity, including integration into existing lymphatics.

Conclusions:

• M-LECP play a significant role in tumor lymphatic development and expansion.
• Understanding M-LECP mechanisms offers potential for novel therapeutic strategies against cancer metastasis.
• Targeting M-LECP could suppress tumor lymphangiogenesis and lymph node metastasis.